Literature DB >> 24891166

Molecular diagnostics for thyroid nodules: the current state of affairs.

Sann Yu Mon1, Steven P Hodak2.   

Abstract

Molecular diagnostics offers great promise for the evaluation of cytologically indeterminate thyroid nodules. Numerous molecular genetic and immunohistochemical tests have been developed that may be performed on thyroid specimens obtained during standard fine-needle aspiration, some of which may greatly improve diagnostic yield. A sound understanding of the diagnostic performance of these tests, and how they can enhance clinical practice, is important. This article reviews the diagnostic utility of immunohistochemical and molecular testing for the clinical assessment of thyroid nodules, and makes recommendations about how these tests can be integrated into clinical practice for patients with cytologically indeterminate thyroid nodules.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypia of uncertain significance/follicular lesion of uncertain significance; Follicular neoplasm/suspicious for follicular neoplasm; Genetic mutations in thyroid cancer; Immunohistochemical tests; Molecular diagnosis for thyroid nodules; Suspicious for malignant cells

Mesh:

Year:  2014        PMID: 24891166     DOI: 10.1016/j.ecl.2014.02.015

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  2 in total

1.  Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.

Authors:  Aisen Zhang; Cheng Wang; Hui Lu; Xi Chen; Yi Ba; Chunni Zhang; Chen-Yu Zhang
Journal:  Dis Markers       Date:  2019-09-16       Impact factor: 3.434

2.  Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration.

Authors:  Erik Kouba; Andrew Ford; Charmaine G Brown; Chen Yeh; Gene P Siegal; Upender Manne; Isam-Eldin Eltoum
Journal:  Am J Clin Pathol       Date:  2018-07-03       Impact factor: 2.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.